Corrigendum to “Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways”. (International Immunopharmacology (2019) 66 (41–51), (S1567576918304521), (10.1016/j.intimp.2018.11.006)) Other Scholarly Work

Huang, Q, Zhang, X, Bai, F et al. (2020). Corrigendum to “Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways”. (International Immunopharmacology (2019) 66 (41–51), (S1567576918304521), (10.1016/j.intimp.2018.11.006)) . INTERNATIONAL IMMUNOPHARMACOLOGY, 79 10.1016/j.intimp.2019.106117

cited authors

  • Huang, Q; Zhang, X; Bai, F; Nie, J; Wen, S; Wei, Y; Wei, J; Huang, R; He, M; Lu, Z; Lin, X

authors

abstract

  • The authors regret that the wrong Fig. 1 (A3 to A5) was published. The correct figures are provided in this corrigendum. The authors would like to apologize for any inconvenience caused. [Figure presented]

publication date

  • February 1, 2020

published in

Digital Object Identifier (DOI)

volume

  • 79